BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20513052)

  • 21. [Optimal choice of antibiotic for local use in patients with external otitis and furuncles in the acoustic meatus].
    Balandin AB; Dimova AD
    Vestn Otorinolaringol; 2004; (2):43-5. PubMed ID: 15139356
    [No Abstract]   [Full Text] [Related]  

  • 22. Otitis externa: management of the recalcitrant case.
    Selesnick SH
    Am J Otol; 1994 May; 15(3):408-12. PubMed ID: 8579150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tacrolimus ointment 0.1% in pityriasis alba: an open-label, randomized, placebo-controlled study.
    Rigopoulos D; Gregoriou S; Charissi C; Kontochristopoulos G; Kalogeromitros D; Georgala S
    Br J Dermatol; 2006 Jul; 155(1):152-5. PubMed ID: 16792767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tacrolimus in the treatment of severe chronic idiopathic urticaria: an open-label prospective study.
    Kessel A; Bamberger E; Toubi E
    J Am Acad Dermatol; 2005 Jan; 52(1):145-8. PubMed ID: 15627098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful treatment of chronic ulcerated necrobiosis lipoidica with 0.1% topical tacrolimus ointment.
    Clayton TH; Harrison PV
    Br J Dermatol; 2005 Mar; 152(3):581-2. PubMed ID: 15787840
    [No Abstract]   [Full Text] [Related]  

  • 26. [The anti-calcineurins (cyclosporin and tacrolimus)].
    Raymond S; Limat S; Woronoff-Lemsi MC
    Soins; 2007 Jun; (716):61-3. PubMed ID: 17718044
    [No Abstract]   [Full Text] [Related]  

  • 27. Ciprofloxacin: drug of choice in the treatment of malignant external otitis (MEO).
    Levenson MJ; Parisier SC; Dolitsky J; Bindra G
    Laryngoscope; 1991 Aug; 101(8):821-4. PubMed ID: 1865729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant external otitis in a diabetic renal transplant patient. Successful treatment without discontinuation of immunosuppressive therapy.
    Britigan BE; Blythe WB
    Transplantation; 1987 May; 43(5):769-71. PubMed ID: 3554673
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term efficacy of topical tacrolimus on oral lesions of chronic graft-versus-host disease.
    Fricain JC; Sibaud V; Swetyenga N; Tabrizi R; Campana F; Taïeb A
    Br J Dermatol; 2007 Mar; 156(3):588-90. PubMed ID: 17300261
    [No Abstract]   [Full Text] [Related]  

  • 30. Short-term efficacy of tacrolimus ointment in severe uremic pruritus.
    Pauli-Magnus C; Klumpp S; Alscher DM; Kuhlmann U; Mettang T
    Perit Dial Int; 2000; 20(6):802-3. PubMed ID: 11216583
    [No Abstract]   [Full Text] [Related]  

  • 31. Identification and antimicrobial susceptibility of bacteria and yeasts isolated from healthy dogs and dogs with otitis externa.
    Lyskova P; Vydrzalova M; Mazurova J
    J Vet Med A Physiol Pathol Clin Med; 2007 Dec; 54(10):559-63. PubMed ID: 18045339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities.
    Furlong T; Storb R; Anasetti C; Appelbaum FR; Deeg HJ; Doney K; Martin P; Sullivan K; Witherspoon R; Nash RA
    Bone Marrow Transplant; 2000 Nov; 26(9):985-91. PubMed ID: 11100278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conversion from cyclosporine to tacrolimus in pediatric kidney transplant recipients.
    Ferraresso M; Ghio L; Edefonti A; Garavaglia R; Berardinelli L
    Pediatr Nephrol; 2002 Aug; 17(8):664-7. PubMed ID: 12185478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation.
    Bechstein WO; Neuhaus P; McMaster P; Calne R; Pichlmayr R; Otto G; Williams R; Ericzon BG; Bismuth H
    Transplant Proc; 1996 Apr; 28(2):1008-10. PubMed ID: 8623211
    [No Abstract]   [Full Text] [Related]  

  • 35. Annular erythema responding to tacrolimus ointment.
    Rao NG; Pariser RJ
    J Drugs Dermatol; 2003 Aug; 2(4):421-4. PubMed ID: 12884468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment with tacrolimus in autoimmune diseases].
    Sádaba B; Azanza JR; García Quetglas E; Fernández V
    Rev Med Univ Navarra; 2004; 48(3):24-38. PubMed ID: 15622922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease.
    Couriel DR; Saliba R; Escalón MP; Hsu Y; Ghosh S; Ippoliti C; Hicks K; Donato M; Giralt S; Khouri IF; Hosing C; de Lima MJ; Andersson B; Neumann J; Champlin R
    Br J Haematol; 2005 Aug; 130(3):409-17. PubMed ID: 16042691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders.
    Cheng AC; Yuen K; Chan W
    Cornea; 2006 Jun; 25(5):634; author reply 634. PubMed ID: 16783160
    [No Abstract]   [Full Text] [Related]  

  • 39. Tacrolimus ointment for the treatment of atopic dermatitis.
    Boucher M
    Issues Emerg Health Technol; 2001 Jul; (19):1-4. PubMed ID: 11776288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of an ear cleanser for the treatment of infectious otitis externa in dogs.
    Cole LK; Kwochka KW; Kowalski JJ; Hillier A; Hoshaw-Woodard SL
    Vet Ther; 2003; 4(1):12-23. PubMed ID: 12756632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.